Product Information
CLINDAMYC-BNZ PEROX 1.2-3.75% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.4723 per GM under NDC 45802038301. Its NADAC has been published 98 times since Oct 9, 2024.
FDA first approved this application on Aug 20, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5; 10 mg/g; mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802038301
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209610FDA Approved
8/20/2024
TE Code
AB
On Market Since
9/20/2024
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has been published 98 times since Oct 9, 2024, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4723 per GM |
|---|---|
| All-time high | $5.9100 (Nov 13, 2024) |
| All-time low | $2.3828 (Jun 17, 2026) |
| 52-week high | $4.6087 |
| 52-week low | $2.3828 |
| Median price | $4.1492 |
| Average price | $4.0998 |
| Largest weekly change | -22.2% (Apr 22, 2026) |
| Weeks tracked | 98 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDAMYC-BNZ PEROX 1.2-3.75%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYC-BNZ PEROX 1.2-3.75%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.4723 per GM (NDC 45802038301), effective Aug 19, 2026.
How has the price of CLINDAMYC-BNZ PEROX 1.2-3.75% changed over time?
Over the history we have for it, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has declined 51.5%. It has been tracked across 98 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for CLINDAMYC-BNZ PEROX 1.2-3.75%?
Since Oct 9, 2024, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has ranged from a low of $2.3828 (Jun 17, 2026) to a high of $5.9100 (Nov 13, 2024), with a median of $4.1492 per GM.
Are there cheaper alternatives to CLINDAMYC-BNZ PEROX 1.2-3.75%?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYC-BNZ PEROX 1.2-3.75% in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYC-BNZ PEROX 1.2-3.75%?
CLINDAMYC-BNZ PEROX 1.2-3.75% (NDC 45802038301) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.